semaglutide gastrointestinal obstruction law firm in michigan The FDA sent a warning letter to the maker of Ozempic and Wegovy over unreported potential GLP-1 side effects. Here's what to know The FDA sent a warning

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

Retatrutide is a synthetic peptide that has been studied in scientific research for its interaction with glucose-regulating and metabolic signaling pathways

TRANSCEND-T2D-1: Retatrutide in adults with obesity and type 2 diabetes

It contains semaglutide, which belongs to the class of drugs known as GLP-1 receptor agonists

A Colorado woman shares how an underrecognized disorder affected her youth and how a clinical trial on semaglutide finally turned her life around.

You're not just losing weight you're shifting what kind of tissue remains